FDA approves second RSV vaccine for people older than 60

The U.S. Food and Drug Administration approved Pfizer ' s respiratory syncytial virus vaccine on Wednesday. The vaccine, called ABRYSVO, is the second RSV vaccine for people older than 60 to be approved by the FDA.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news